hyperosmolarity-triggered inflammatory cascade
Feb 26, 2019
Notizia
Vertex, CRISPR Therapeutics treated a patient using CRISPR In the very first, a patient diagnosed with Beta thalassemia was treated using CRISPR gene editing tool by Vertex and CRISPR Therapeutics. CTX001 used to treat the disease, was extracted from hematopoietic stem cells from patients, engineered ex...
Read More...
-Agonist.png "Toll-like Receptors Agonist")
